Clinical trial for Ventricular Tachycardia
Official title Peri-Procedural Transmural Electrophysiological (EP) Imaging of Scar-Related Ventricular Tachycardia
ClinicalTrials.gov ID: NCT03713866
What this study is testing
- What it's testing
- The study wants to see if combining ECG‑based imaging with CT or MRI scans can better locate the abnormal heart circuits before ablation and explain why ablation sometimes fails.
- Who it's for
- Adults who have ventricular tachycardia caused by scar tissue from a previous heart attack.
- What's involved
- Participants will have a special ECG imaging test before their catheter ablation, the usual ablation procedure, and another ECG imaging test afterward, plus any standard scans and check‑ups.
- Time commitment
- The study involves the ablation procedure day and a few follow‑up visits over several weeks to months.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- One or more episodes of sustained monomorphic VT
- Referred for catheter ablation
- Previously implanted ICD
- Signed the patient informed consent form
- Able and willing to comply with all pre-, post-, and follow-up testing and requirements
You likely can't join if
- Have estimated Glomerular Filtration Ratio (eGFR) less than 30
- Have a life expectancy less than 6 months or are listed for heart transplantation at time of inclusion
- Are pregnant
- Are on IV inotropic agents
- Have any contraindication to catheter ablation (including but not limited to mechanical prosthetic aortic and mitral valves, known protruding Left...
- New York Heart Association (NYHA) functional class IV
See the full eligibility criteria
- One or more episodes of sustained monomorphic VT
- Referred for catheter ablation
- Previously implanted ICD
- Signed the patient informed consent form
- Able and willing to comply with all pre-, post-, and follow-up testing and requirements
- Have estimated Glomerular Filtration Ratio (eGFR) less than 30
- Have a life expectancy less than 6 months or are listed for heart transplantation at time of inclusion
- Are pregnant
- Are on IV inotropic agents
- Have any contraindication to catheter ablation (including but not limited to mechanical prosthetic aortic and mitral valves, known protruding Left Ventricular (LV) thrombus
- New York Heart Association (NYHA) functional class IV
- Had ST wave elevation myocardial infarction within \< 1 month
- Unwilling or unable to undergo cardiac MRI scan AND unwilling or unable to undergo cardiac CT scan (e.g. contrast allergy).
The study team makes the final eligibility decision.
Where it is enrolling
- Halifax, Nova Scotia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Halifax, Nova Scotia, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.